ALGS vs BABA · rev $3.6M vs P/E 20, rev $137.30B
Aligos Therapeutics Inc (ALGS) versus Alibaba Group Holding Ltd (BABA) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
ALGS currently screens at market cap $44.1M. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Not investment advice. Open the ALGS and BABA stock pages for the full models.
Not investment advice.